πŸ§ͺ HPLC Verified β€” β‰₯99% Purity Guaranteed🚚 Free Shipping on Orders Over $200πŸ‡ΊπŸ‡Έ 100% USA Manufactured & SourcedπŸ“„ COA Available for Every Batchβœ… Third-Party Tested for Purity & Identityβš—οΈ New Arrivals β€” Shop the Latest Research CompoundsπŸ§ͺ HPLC Verified β€” β‰₯99% Purity Guaranteed🚚 Free Shipping on Orders Over $200πŸ‡ΊπŸ‡Έ 100% USA Manufactured & SourcedπŸ“„ COA Available for Every Batchβœ… Third-Party Tested for Purity & Identityβš—οΈ New Arrivals β€” Shop the Latest Research Compounds
Homeβ€ΊShopβ€ΊKLOW
KLOW
COA Coming Soon β€” View COA Directory
Blends

Quantity

$159.99$199.99SAVE $40.00

KLOW is a proprietary research peptide blend. 80mg vial. Studied for metabolic and inflammatory pathway modulation.

⚠️ For research purposes only. Not for human consumption. By purchasing you confirm you are a qualified researcher.

KLOW Overview

The KLOW Blend combines GHK-Cu, BPC-157, TB-500, and KPV into a single formulation studied for its potential influence on molecular signaling and systemic regulation. In laboratory and preclinical models, these peptides have been investigated for their effects on matrix remodeling, angiogenesis, cytokine modulation, and extracellular matrix activity. Together, they provide a platform for exploring synergistic pathways in molecular dynamics, immune signaling, and vascular biology.Pickart L. & Margolina A. 2018

KLOW Structure

GHK-Cu molecular structure

GHK-Cu

CAS #: 49557-75-7

Formula: C₁₄Hβ‚‚β‚„CuN₆Oβ‚„

Weight: 340.9 g/mol

PubChem ID: 5311476

BPC-157 molecular structure

BPC-157

CAS #: 137525-51-0

Formula: C₁₄Hβ‚‚β‚„CuN₆Oβ‚„

Weight: 340.9 g/mol

PubChem ID: 5311476

TB-500 molecular structure

TB-500

CAS #: 77591-33-4

Formula: C₂₁₂H₃₅₀N₅₆Oβ‚‡β‚ˆS

Weight: 4963.5 g/mol

PubChem ID: 16132321

KPV molecular structure

KPV

CAS #: 67727-97-3

Formula: C₁₆H₃₀Nβ‚„Oβ‚„

Weight: 358.44 g/mol

PubChem ID: 67727

Research Findings

The KLOW Blend, which combines GHK-Cu, BPC-157, TB-500, and KPV, has been studied in structural, vascular, epithelial, and systemic models. Research highlights activity in collagen formation, extracellular matrix remodeling, angiogenesis, molecular migration, and cytokine modulation. The inclusion of KPV further supports immune signaling and cytokine-modulating pathways, expanding the experimental scope of this blend in preclinical settings.

Key Areas of Research:

  • Structural: Collagen, matrix, connective signalingVascular: Angiogenesis, nitric oxide, remodelingEpithelial: Migration, matrix signaling, follicle dynamicsSystemic: Cytokine modulation, immune signaling, pathway dynamicsTogether, these findings suggest broad experimental potential for the KLOW Blend across multiple biological pathways. By combining structural support, vascular and epithelial activity, and immune signaling, the KLOW Blend provides a versatile platform for research into molecular dynamics, matrix characterization, and systemic resilience in laboratory settings.Sikiric P. et al., 2020

References

Pickart L. et al. (2015). GHK-Cu and regulation of multiple biological processes in aging and repair. BioMed Res Int.Sikiric P. et al. (1993). A new gastric peptide, BPC-157, characterized and synthesized. Peptides, 14(1):127–131.Goldstein A.L. et al. (2005). Thymosin beta-4 and tissue regeneration: potential mechanisms of action. Ann N Y Acad Sci.

Same Category

Related Compounds